| Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ... Cancer discovery 4 (2), 216-231, 2014 | 687 | 2014 |
| The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, ... PLoS genetics 10 (7), e1004475, 2014 | 418 | 2014 |
| Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends … DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ... Journal for immunotherapy of cancer 8 (1), 2020 | 376 | 2020 |
| Pembrolizumab in relapsed and refractory mycosis fungoides and Sézary syndrome: a multicenter phase II study MS Khodadoust, AH Rook, P Porcu, F Foss, AJ Moskowitz, A Shustov, ... Journal of Clinical Oncology 38 (1), 20, 2020 | 189 | 2020 |
| Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ... Nature Genetics 53 (1), 86-99, 2021 | 147 | 2021 |
| MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma ME Yohe, BE Gryder, JF Shern, YK Song, HC Chou, S Sindiri, A Mendoza, ... Science translational medicine 10 (448), eaan4470, 2018 | 124 | 2018 |
| Genomic classification and clinical outcome in rhabdomyosarcoma: a report from an international consortium JF Shern, J Selfe, E Izquierdo, R Patidar, HC Chou, YK Song, ME Yohe, ... Journal of Clinical Oncology 39 (26), 2859-2871, 2021 | 115 | 2021 |
| MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer … W Chang, AS Brohl, R Patidar, S Sindiri, JF Shern, JS Wei, YK Song, ... Clinical cancer research 22 (15), 3810-3820, 2016 | 107 | 2016 |
| APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors N Roper, S Gao, TK Maity, AR Banday, X Zhang, A Venugopalan, ... Cell Reports 26 (10), 2651-2666. e6, 2019 | 101 | 2019 |
| Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T Cell Receptors in High-risk MYCN-not-amplified Human Neuroblastoma JS Wei, IB Kuznetsov, S Zhang, YK Song, S Asgharzadeh, S Sindiri, ... Clinical Cancer Research, clincanres. 0599.2018, 2018 | 100 | 2018 |
| The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas A Pemov, H Li, R Patidar, NF Hansen, S Sindiri, SW Hartley, JS Wei, ... Oncogene 36 (22), 3168-3177, 2017 | 91 | 2017 |
| Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1–associated atypical … A Pemov, NF Hansen, S Sindiri, R Patidar, CS Higham, E Dombi, ... Neuro-oncology 21 (8), 981-992, 2019 | 82 | 2019 |
| Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma AS Brohl, R Patidar, CE Turner, X Wen, YK Song, JS Wei, KA Calzone, ... Genetics in Medicine 19 (8), 955-958, 2017 | 73 | 2017 |
| Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment H Sun, S Cao, RJ Mashl, CK Mo, S Zaccaria, MC Wendl, SR Davies, ... Nature Communications 12 (1), 1-20, 2021 | 71 | 2021 |
| A mutational comparison of adult and adolescent and young adult (AYA) colon cancer JV Tricoli, LA Boardman, R Patidar, S Sindiri, JS Jang, WD Walsh, ... Cancer 124 (5), 1070-1082, 2018 | 52 | 2018 |
| TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney SL Gooskens, S Gadd, JMG Auvil, DS Gerhard, J Khan, R Patidar, ... Oncotarget 6 (18), 15828, 2015 | 51 | 2015 |
| Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma J Kim, N Light, V Subasri, EL Young, T Wegman-Ostrosky, DA Barkauskas, ... JCO Precision Oncology 5, 75-87, 2021 | 35 | 2021 |
| Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma JS Wei, P Johansson, L Chen, YK Song, C Tolman, S Li, L Hurd, ... PloS one 8 (10), e77731, 2013 | 34 | 2013 |
| Targeted resequencing of pediatric rhabdomyosarcoma: report from the Children’s Oncology Group, the Children’s Cancer and Leukaemia Group, The Institute of Cancer Research UK … JF Shern, R Patidar, Y Song, A Walton, JS Wei, X Wen, ER Rudzinski, ... Journal of Clinical Oncology 36 (15_suppl), 10515-10515, 2018 | 11 | 2018 |
| Relationship of DNA methylation to mutational changes and transcriptional organization in fusion‐positive and fusion‐negative rhabdomyosarcoma W Sun, B Chatterjee, JF Shern, R Patidar, Y Song, Y Wang, RL Walker, ... International Journal of Cancer, 2019 | 10 | 2019 |
Javed KhanDeputy Branch Chief Genetics Branch, Senior Investigator, Center for Cancer Research, NCI, NIHVerified email at mail.nih.gov
